
In the mid-term performance, a "Davis Double Play" occurred, with Guolian Minsheng's net profit increasing by 11.85 times, focusing on allocations in non-ferrous metals and pharmaceuticals

I'm PortAI, I can summarize articles.
The market is good, and the operations are also good
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

